Nicaragua Transfusion Diagnostics Market Opportunities

This new report from is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests 
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Competitive Assessments
- Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis
- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT.

Current and Emerging Products
- Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays.
- Review of automated and semi-automated molecular and immunohematology analyzers.

Technology Review
- Assessment of current and emerging technologies, and their potential applications for the blood banking market.
- Comprehensive lists of companies developing or marketing new technologies and products, by test.

Blood Group Genotyping
PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays
BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Strategic Recommendations
- New product development opportunities for blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
 

Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher

I. Introduction

II. Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Blood Group Genotyping
3. Infectious Disease Screening Tests
a. AIDS
b. Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis D (Delta Agent)
c. Cytomegalovirus
d. Syphilis
e. West Nile Virus
f. Parvovirus B19
g. Creutzfeldt-Jakob’s Disease
h. Malaria
i. Chagas Disease
j. Babesiosis
4. Pathogen Reduction
5. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Automated
and Semiautomated Analyzers
C. Major In Vitro Diagnostic Technologies
and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

III. Market Size and Growth: Volume and Sales Forecasts for 40 Blood
Typing, Grouping and Infectious Disease Screening Tests

IV. Major Product Development Opportunities
A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Competitive Assessments

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
OrthoQuidel
Proteome Sciences
Quest Diagnostics
Roche
Siemens Healthineers
Tecan
Thermo Fisher
Quest Diagnostics

List Of Tables

Executive Summary Table: Total Blood Bank
Test Volume and Reagent Sales
Forecast by Test Category
All Market Segments Blood Typing
And Grouping Test Volume Forecast
All Market Segments Infectious
Disease Screening Test Volume Forecast
All Market Segments Blood Typing
And Grouping Reagent Market
Forecast by Major Test
All Market Segments Infectious
Disease Screening Reagent Market
Forecast by Test
Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or
Marketing HLA Typing Tests
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Hepatitis Tests
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Syphilis Tests
Major Companies Developing or
Marketing Blood Bank Analyzers

Fill The Form For Sample Request

There is no Reviews available